Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × etoposide phosphate × Clear all

Sponsor

Conditions

Lymphoma 9 Leukemia, Myeloid, Acute 8 Hodgkin Disease 8 Lymphoma, Non-Hodgkin 6 Leukemia 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Sarcoma 4 Recurrence 4 Neuroblastoma 4 Multiple Myeloma 4 Central Nervous System Neoplasms 4 Lymphoma, T-Cell 3 Burkitt Lymphoma 3 Teratoma 2 Small Cell Lung Carcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Optic Nerve Glioma 2 Oligodendroglioma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Congenital Abnormalities 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2

Interventions

Carboplatin 21 Cisplatin 14 pembrolizumab 12 Paclitaxel 12 Gemcitabine 12 Pemetrexed 9 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 6 durvalumab 5 Fluorouracil 5 Docetaxel 5 Cyclophosphamide 5 Axitinib 5 Albumin-Bound Paclitaxel 5 osimertinib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 vosaroxin 2 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡